BioHarvest Sciences Inc.
BHSC
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 22.43M | 19.13M | 15.85M | 12.67M | 10.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.43M | 19.13M | 15.85M | 12.67M | 10.60M |
| Cost of Revenue | 10.32M | 9.29M | 8.01M | 7.04M | 6.59M |
| Gross Profit | 12.11M | 9.84M | 7.84M | 5.63M | 4.01M |
| SG&A Expenses | 15.51M | 13.53M | 12.91M | 12.23M | 11.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.28M | 26.89M | 24.71M | 22.64M | 20.55M |
| Operating Income | -7.85M | -7.76M | -8.86M | -9.97M | -9.95M |
| Income Before Tax | -17.19M | -16.23M | -18.39M | -12.56M | -8.14M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.19 | -16.23 | -18.39 | -12.56 | -8.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.19M | -16.23M | -18.39M | -12.56M | -8.14M |
| EBIT | -7.85M | -7.76M | -8.86M | -9.97M | -9.95M |
| EBITDA | -6.84M | -6.88M | -8.13M | -9.24M | -9.26M |
| EPS Basic | -1.19 | -1.16 | -1.34 | -0.91 | -0.62 |
| Normalized Basic EPS | -0.74 | -0.73 | -0.83 | -0.57 | -0.39 |
| EPS Diluted | -1.19 | -1.16 | -1.34 | -0.91 | -0.62 |
| Normalized Diluted EPS | -0.74 | -0.73 | -0.83 | -0.57 | -0.39 |
| Average Basic Shares Outstanding | 61.48M | 57.56M | 54.63M | 54.19M | 52.87M |
| Average Diluted Shares Outstanding | 61.48M | 57.56M | 54.63M | 54.19M | 52.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
